Koska, Juraj
Sands, Michelle
Burciu, Camelia
D’Souza, Karen M.
Raravikar, Kalyani
Liu, James
Truran, Seth
Franco, Daniel A.
Schwartz, Eric A.
Schwenke, Dawn C.
D’Alessio, David
Migrino, Raymond Q.
Reaven, Peter D.
Clinical trials referenced in this document:
Documents that mention this clinical trial
Exenatide Protects Against Glucose- and Lipid-Induced Endothelial Dysfunction: Evidence for Direct Vasodilation Effect of GLP-1 Receptor Agonists in Humans
https://doi.org/10.2337/db14-0976
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (R21HL-092344-01)
U.S. Department of Veterans Affairs (1I01CX000598)
U.S. Department of Veterans Affairs (BLRD I01BX007080)
American Diabetes Association (1-10-CT-31)
Amyloidosis Foundation